2020/09/17

Dr. Yuling Li, CEO of Innoforce, participated ACMC2020

Dr. Yuling Li, CEO of Innoforce, presided over the “downstream separation and purification” session of The 2nd Asia Biopharma Continuous Manufacuturing and Process Innovation Conference 2020.

On September 17, 2020, Dr. Yuling Li, CEO of Innoforce, presided over the “downstream separation and purification” session at the 2nd Asia Biopharma Continuous Manufacturing and Process Innovation Conference 2020”. She also presented a lecture on ” Ensuring Viral Safety for Mab and Advanced Therapeutic Medical Products ” to the participants.

Please scan the 2D code for more details

SEE OTHERS

2022/12/02

Innoforce Opens GMP Manufacturing Facility & Corporate Headquarters in Hangzhou, China to Provide CDMO Services for Global Supply of RNA, Cell & Gene Therapies

2022/08/31

Dr. Yuling Li, CEO of Innoforce, participated ACMC2020

SEE OTHERS

Innoforce Opens GMP Manufacturing Facility & Corporate Headquarters in Hangzhou, China to Provide CDMO Services for Global Supply of RNA, Cell & Gene Therapies

Innoforce, Mayo Clinic & Hibiscus BioVentures launch Mayflower BioVentures

Innoforce and Hibiscus BioVentures Announce Strategic Partnership

Innoforce Completes Second Tranche of Series A Financing